School of Chemistry, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9ST, UK.
GSK, Stevenage, SG1 2NY, UK.
Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12492-12497. doi: 10.1002/anie.201705639. Epub 2017 Aug 30.
The uridyl peptide antibiotics (UPAs), of which pacidamycin is a member, have a clinically unexploited mode of action and an unusual assembly. Perhaps the most striking feature of these molecules is the biosynthetically unique 3'-deoxyuridine that they share. This moiety is generated by an unusual, small and monomeric dehydratase, Pac13, which catalyses the dehydration of uridine-5'-aldehyde. Here we report the structural characterisation of Pac13 with a series of ligands, and gain insight into the enzyme's mechanism demonstrating that H42 is critical to the enzyme's activity and that the reaction is likely to proceed via an E1cB mechanism. The resemblance of the 3'-deoxy pacidamycin moiety with the synthetic anti-retrovirals, presents a potential opportunity for the utilisation of Pac13 in the biocatalytic generation of antiviral compounds.
尿嘧啶肽类抗生素(UPAs),其中包括帕昔霉素,具有未被临床开发的作用模式和不寻常的结构。这些分子最显著的特点之一是它们共同具有生物合成独特的 3'-脱氧尿苷。这个部分是由一种不寻常的、小的和单体的脱水酶 Pac13 产生的,它催化尿苷-5'-醛的脱水。在这里,我们报告了一系列配体对 Pac13 的结构特征,并深入了解了该酶的机制,证明 H42 对酶的活性至关重要,并且该反应可能通过 E1cB 机制进行。3'-脱氧帕昔霉素部分与合成抗逆转录病毒药物的相似性,为利用 Pac13 生物催化生成抗病毒化合物提供了潜在的机会。